GSK Product Portfolio
00173089601
1
INJECTION
belantamab mafodotin-blmf
Discontinued
This Product is no longer sold by GlaxoSmithKline. Date of Discontinuation was February 6, 2023.
00173091301
1
SINGLE-DOSE VIAL
belantamab mafodotin-blmf
Active
00173092245
1
TABLETS
gepotidacin
Active
58160084252
10
PREFILLED SYRINGES WITHOUT NEEDLE
diptheria and tetanus toxoids and acellular pertussus
Active
58160084211
10
SINGLE-DOSE VIALS
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Absorbed
Discontinued
This product is no longer sold by GSK. Date of Discontinuation was September 11, 2024.
BREO ELLIPTA 100/25 MCG INH PWDR 14 DOSE NDPI INST PAC X 1
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
00173085914
0
POWDER
fluticasone furoate and vilanterol inhalation powder
Active
BREO ELLIPTA 100/25 MCG INH PWDR 30 DS NDPI TRD PACK X 1
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
00173085910
0
POWDER
fluticasone furoate and vilanterol inhalation powder
Active
BREO ELLIPTA 200/25 MCG INH PWDR 1X 14D INST
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
00173088214
0
POWDER
fluticasone furoate and vilanterol inhalation powder
Active
BREO ELLIPTA 200/25 MCG INH PWDR 1X 30D
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
Prescribing Information, including BOXED WARNING
Material Safety Data Sheet
00173088210
0
POWDER
fluticasone furoate and vilanterol inhalation powder
Active
BREO ELLIPTA 50 / 25 MCG INH PWDR 30 DS NDPI TRD PACK X 1
Prescribing Information
Material Safety Data Sheet
HDA
Prescribing Information
Material Safety Data Sheet
HDA
00173091610
1
POWDER
fluticasone furoate and vilanterol inhalation powder
Active